114 related articles for article (PubMed ID: 11699412)
21. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
Ezzat S; Zheng L; Kolenda J; Safarian A; Freeman JL; Asa SL
Thyroid; 1996 Oct; 6(5):409-16. PubMed ID: 8936664
[TBL] [Abstract][Full Text] [Related]
23. N-ras gene mutations in childhood acute non-lymphoblastic leukemia.
Terada N; Smith TJ; Stork LC; Odom LF; Gelfand EW
Leuk Res; 1991; 15(10):935-41. PubMed ID: 1921453
[TBL] [Abstract][Full Text] [Related]
24. N-RAS and K-RAS gene mutations in Brazilian patients with multiple myeloma.
Ortega MM; Faria RM; Shitara ES; Assis AM; Albuquerque DM; Oliveira JS; Noguti MA; Faria JR; Costa FF; Lima CS
Leuk Lymphoma; 2006 Feb; 47(2):285-9. PubMed ID: 16321859
[TBL] [Abstract][Full Text] [Related]
25. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
26. N-ras mutations in radiation-induced murine leukemic cells.
Rithidech KN; Dunn JJ; Gordon CR; Cronkite EP; Bond VP
Blood Cells Mol Dis; 1996; 22(3):271-80. PubMed ID: 9075579
[TBL] [Abstract][Full Text] [Related]
27. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
28. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
29. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
Jacobson DR; Mills NE
Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
[TBL] [Abstract][Full Text] [Related]
30. Point mutations in both transforming and non-transforming codons of the N-ras proto-oncogene of Ph+ leukemias.
Rovera G; Reichard BA; Hudson S; Bittenbender S; Yamada M; Tournay O; Preisler HD
Oncogene; 1989 Jul; 4(7):867-72. PubMed ID: 2666907
[TBL] [Abstract][Full Text] [Related]
31. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
32. Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer.
Miyakura Y; Sugano K; Fukayama N; Konishi F; Nagai H
Jpn J Clin Oncol; 2002 Jun; 32(6):219-21. PubMed ID: 12110640
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.
Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694
[TBL] [Abstract][Full Text] [Related]
34. [Incidence of point mutations in Ki-ras codon 12 and 13 in squamous epithelial carcinomas of the head-neck region].
Rathcke IO; Gottschlich S; Görögh T; Lippert BM; Werner JA
Laryngorhinootologie; 1996 Aug; 75(8):465-70. PubMed ID: 8962608
[TBL] [Abstract][Full Text] [Related]
35. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
37. [Detection of K-ras and p-53 oncogene mutations in a patient with acute lymphoblastic leukemia before and after bone marrow transplantation].
Ilic V; Cikota B; Vojvodic D; Malesevic M; Stamatovic D; Magic Z
Vojnosanit Pregl; 2001; 58(5):557-61. PubMed ID: 11769422
[TBL] [Abstract][Full Text] [Related]
38. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
40. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]